For the day 1 clinical measure scores (MADRS, QIDSSR, M3VAS, SHAPS, TEPS-A and TEPS-C), linear mixed-effects models were also used with condition (placebo and naltrexone), time (preinfusion and day 1 postinfusion), visit (visit 1 and visit 2) and the interaction between condition and time as fixed effects
Its crucial to consult the specific products dosing instructions to ensure accurate conversions and optimal dosing
Side Effects and Safety Profile Like most incretin agonists, retatrutide can produce mild to moderate gastrointestinal side effects during dose escalation
Sometimes we can manage eye problems with closer monitoring, laser treatment, or injections while you continue your GLP-1 medication
What are the side effects of these medications